IR News

Sep. 02, 2022Print(PDF/585KB)Corporate

Sumitomo Pharma Announces Personnel Changes

Sumitomo Pharma Co., Ltd. (Head Office: Osaka, Japan; Representative Director, President and CEO: Hiroshi Nomura) today announced the following personnel changes:

Changes in Personnel (effective October 1, 2022)

Drug Research (Division)
Position as of October 1, 2022 Current position Name
Senior Project Director,
Early-phase Drug Research		 Senior Director, Platform Technology Research Unit Hidetaka Nagata
Senior Project Director,
Late-phase Drug Research		 Director, Pharmacology Group I, Pharmacology Research Unit Taro
Kato
Senior Director, Platform Technology Research Unit Senior Project Director, Early-phase Drug Research Masakazu Hashimoto
Drug Development (Division)
Position as of October 1, 2022 Current position Name
Senior Director, Development Planning & Management Senior Director, Oncology Clinical Development Unit Senior Director, Development Planning & Management Katsunori Maruta